Page 5 - Largest South Korean (KOSPI) Pharmaceuticals & Biotech Stocks by Market Cap

UPDATED Nov 28, 2024

Discover large cap South Korean Pharmaceuticals & Biotech companies that are on the KOSPI. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

255 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

A293780

AptaBio Therapeutics
₩6,730.005.8%-16.1%₩180.9bn/aPS62.3xn/an/a

A086890

ISU Abxis
₩5,010.00-0.8%-15.9%₩179.9bn/aPS2.9xn/an/a

A950210

Prestige BioPharma
₩14,920.00-2.2%50.6%₩179.3bn/aPS260.2xn/an/a

A214390

Kyongbo Pharmaceutical
₩7,440.000%2.9%₩177.9bn/aPE33.2xn/an/a

A234080

JW Lifescience
₩11,550.00-1.7%-8.8%₩178.8bn/aPE6.2xn/a4.3%

A235980

MedPacto
₩5,300.0011.8%-34.7%₩178.0bn/aPB3.2xn/an/a

A011000

GeneOne Life Science
₩2,225.002.1%-23.9%₩177.6bn/aPS4.7xn/an/a

A288330

Bridge Biotherapeutics
₩3,520.0014.5%46.7%₩177.4bn/aPS164304.9xn/an/a

A002390

HANDOK
₩12,860.002.9%-0.08%₩177.0bn/aPB0.6xn/a2.3%

A278650

HLB bioStepLtd
₩2,100.00-2.8%-18.6%₩176.8bn/aPS3.6xn/a0%

A461030

IMB Dx
₩12,430.0015.1%n/a₩174.2bn/an/an/an/a

A182400

NKMAX
₩2,020.000%-69.5%₩172.7bn/aPE11xn/an/a

A115180

Qurient
₩4,860.009.2%45.2%₩172.4bn/aPS19.7xn/an/a

A308430

CellBion
₩13,370.0029.9%n/a₩170.7bn/an/an/an/a

A138610

NIBEC
₩15,600.009.3%-7.0%₩169.9bn/aPS8.8xn/an/a

A060590

CTCBIO
₩7,090.000.6%-25.9%₩169.5bn/aPS1.2xn/an/a

A217330

Cytogen
₩7,140.00-6.7%-46.7%₩164.7bn/aPS26.6xn/an/a

A011040

Kyung Dong Pharmaceutical
₩6,110.000.2%-5.7%₩164.6bn/aPB0.8xn/a6.5%

A038290

Macrogen
₩16,450.001.5%-20.1%₩164.2b₩27,000.00PS1.2xE112.2%1.8%

A023910

Daihan PharmaceuticalLtd
₩27,250.004.8%-1.6%₩160.2b₩36,000.00PE5.2xE0.9%2.8%

A065660

Anterogen.Co.Ltd
₩15,570.00-1.3%12.3%₩151.5bn/aPS22.8xn/an/a

A106190

High Tech Pharm
₩14,090.00-10.8%58.6%₩149.8bn/aPE10.3xn/a0.7%

A001360

SAMSUNG PHARM
₩1,581.004.2%-31.9%₩148.8bn/an/an/an/a

A217730

Kangstem Biotech
₩2,580.00-3.9%43.0%₩144.6bn/aPS10.9xn/an/a
Page 5 of 11
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.